New Delhi [India], Union Health Secretary Apoorva Chandra on Wednesday visited the manufacturing unit of global pharmaceutical company Bilthoven Biologicals in Utrecht, Netherlands.
Additionally, the Union Health Secretary met CEO Juergen Quick in Bilthoven and Jeff de Klerk, CEO of Poonawala Science Park (PSP) on EU pandemic preparedness, partnerships and production of vaccines, the Ministry of Health and Family Welfare said in a press release. Met on cooperation.
"He also met the senior management and was briefed about the various manufacturing units of the facility. A detailed presentation was given on their future manufacturing plans. Bilthoven Biologicals BV Company produces pharmaceutica products like polio, diphtheria-tetanus-polio and vaccines Produces.Tetanus Alone with Bacillus Calmette-Guerin (BCG),'' the press release said Bioengineering and vaccine production firm Bilthoven Biologicals was bought by Serum India Ltd in 2012. This has strengthened its capacity to produce vaccines and also provided it with a valuable. Manufacturing base in Europe Recently, Serum and Bharat Biotech have announced a collaboration to scale up the production of OPV. Bharat Biotech will collaborate with Netherlands-based Bilthoven Biologicals BV, a wholly owned arm of Serum Institute of India. According to a press release, an agreement has been signed under which Bhara Biotech will procure drug substances for the manufacture of oral polio vaccines, which will be supplied.In India and globally. This will contribute to securing supply of oral polio vaccines. With this partnership, BBIL's capacity to manufacture Oral Polio Vaccine (OPV) has increased to 500 million doses every year. The Universal Immunization Program (UIP) of the Union Health Ministry is one of the major interventions to protect children from life-threatening conditions. To provide vaccination including vaccine against polio. India has been certified polio free in March 2014.However, to maintain polio-free status, polio vaccine is administered to children as part of high-quality national and sub-national polio rounds across the country. Continuous supply of OPV is essential to keep India polio free. The partnership between BBIL and Serum will contribute to providing continuous supply of OPV in the country.
Additionally, the Union Health Secretary met CEO Juergen Quick in Bilthoven and Jeff de Klerk, CEO of Poonawala Science Park (PSP) on EU pandemic preparedness, partnerships and production of vaccines, the Ministry of Health and Family Welfare said in a press release. Met on cooperation.
"He also met the senior management and was briefed about the various manufacturing units of the facility. A detailed presentation was given on their future manufacturing plans. Bilthoven Biologicals BV Company produces pharmaceutica products like polio, diphtheria-tetanus-polio and vaccines Produces.Tetanus Alone with Bacillus Calmette-Guerin (BCG),'' the press release said Bioengineering and vaccine production firm Bilthoven Biologicals was bought by Serum India Ltd in 2012. This has strengthened its capacity to produce vaccines and also provided it with a valuable. Manufacturing base in Europe Recently, Serum and Bharat Biotech have announced a collaboration to scale up the production of OPV. Bharat Biotech will collaborate with Netherlands-based Bilthoven Biologicals BV, a wholly owned arm of Serum Institute of India. According to a press release, an agreement has been signed under which Bhara Biotech will procure drug substances for the manufacture of oral polio vaccines, which will be supplied.In India and globally. This will contribute to securing supply of oral polio vaccines. With this partnership, BBIL's capacity to manufacture Oral Polio Vaccine (OPV) has increased to 500 million doses every year. The Universal Immunization Program (UIP) of the Union Health Ministry is one of the major interventions to protect children from life-threatening conditions. To provide vaccination including vaccine against polio. India has been certified polio free in March 2014.However, to maintain polio-free status, polio vaccine is administered to children as part of high-quality national and sub-national polio rounds across the country. Continuous supply of OPV is essential to keep India polio free. The partnership between BBIL and Serum will contribute to providing continuous supply of OPV in the country.
